Peptides for Tanning
The peptides people most often research for tanning, with how much evidence exists for each. A long list does not mean any of them is proven to work in people.
- Peptides listed
- 2
- With human trials
- 1
- FDA approved (any use)
- 0
- Melanotan IIMelanocortin agonistHuman RCT evidence, 4 of 4Life sciences 1996, PMID 8637402Human9Animal3Summarised3Off FDA Category 2 (Apr 2026)Overview
- GHK-CuCopper tripeptideNo study with an outcome for tanningPubMed search, 11 Oct 2026Human2Animal0Summarised0Injectable off Category 2 (Apr 2026)Overview
What this list does not show
Search demand tells you what people are curious about, not what works. Read each peptide's evidence before anything else.
Search interest is not evidence
This list follows what people search for and discuss. It says nothing about how well any peptide works.Animal results may not carry over
Doses, routes and effects seen in rodents or cell dishes often have no tested human equivalent.Approval covers specific uses
An FDA approval applies to the conditions and doses on the label, not to every goal a drug is searched with.Combinations are a separate question
Blends and stacks put several peptides together. Evidence for one peptide is not evidence for the mix.Why tanning is a health question first
MedlinePlus states plainly that a tan, whether outdoor or from a bed, signals skin damage and raises melanoma and skin cancer risk.[11]
MedlinePlus says a tan is a sign of skin damage.[11]
MedlinePlus says tanning pills can be dangerous and are not approved by the FDA.[11]
Melanotan II is the only listed peptide with tanning data in people
Melanotan II has 9 human-only papers and 3 animal papers in the ledger for tanning; GHK-Cu has 2 human papers and no animal ones.
Calculated from source our PubMed count ledger ledger (PubMed title/abstract counts, 2026-10-02); melanotan-2 human only 9, animal only 3, rct 0; ghk-cu human only 2, animal only 0, rct 0. Formula: Counts copied from each peptide ledger: humanOnly = human studies not also tagged animal, animalOnly = animal studies not tagged human, rct = human randomised trials. They count papers mentioning the topic, not positive results.
The core human trial reported increased pigmentation in only some of its subjects, at the face, upper body and buttock, 1 week after dosing ended.[1]
The authors describe this as tanning activity in humans from only 5 low doses given every other day by subcutaneous injection.[1]
A larger observational study of users reports motivations that included a tanned look before sun holidays and fitness or bodybuilding competitions. It describes motives, not safety.[12]
A single case report describes feelings of confidence and attractiveness in one user. That is an experience, not a safety or efficacy outcome.[13]
Common questions
What peptides are used for tanning?
Melanotan II is the one peptide here with human tanning data, and that data is a very small trial.[1]
Are peptide injections for tanning safe?
The tanning studies cited here do not establish safety, and MedlinePlus says tanning of any kind raises the risk of melanoma and other skin cancers.[11]
What is the best peptide for tanning?
No comparison trial is cited, so no peptide can be ranked. Melanotan II has the only human pigmentation measurements here.[1]
Is there an FDA-approved tanning injection?
MedlinePlus says tanning pills are not approved by the FDA.[11]
Explore nearby goals
Sources
- 1Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study.Life sciences · 1996PMID 8637402Accessed 2 Oct 2026
- 2PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) (431 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 3PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (humans[mh] OR patients[tiab] OR volunteers[tiab]) (150 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 4PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (randomized[tiab] OR clinical trial[pt] OR split-face[tiab]) (8 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 5PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (wound[tiab] OR hair[tiab] OR skin[tiab] OR wrinkle*[tiab]) (123 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 6PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (2 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 7PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (rat[tiab] OR mice[tiab] OR rats[tiab] OR animal[tiab]) (80 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 8PubMed search: ("GHK-Cu"[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (facial[tiab] OR cream[tiab] OR photodamage[tiab] OR volunteers[tiab] OR women[tiab]) (6 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 9PubMed search: ("GHK-Cu"[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (hair[tiab] OR alopecia[tiab]) (16 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 10PubMed search: ("GHK-Cu"[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (38 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 11Official web pageOfficial web page · web page
- 12Melanotan II User Experience: A Qualitative Study of Online Discussion Forums.Dermatology (Basel, Switzerland) · 2021PMID 34464955Accessed 2 Oct 2026
- 13An in-depth case examination of an exotic dancer's experience of melanotan.The International journal on drug policy · 2014PMID 24280586Accessed 2 Oct 2026
Found an error? Report a correction.